Kedem Pharmaceuticals (KDMP.OB) to Appoint New Chief Operating Officer
6/27/2012 9:42:29 AM
More...
|
Kedem Pharmaceuticals (KDMP.OB) Introduces Their Sublingual Drug Delivery System to Attendees at the World Money Show in Orlando, Florida
2/7/2012 8:38:22 AM
More...
|
YouTube Interview Now Available for Kedem Pharmaceuticals (KDMP.OB) CEO Dr. Hassan Salari Updating Company Progress on Sublingual Drug Delivery System
2/2/2012 9:56:19 AM
More...
|
Kedem Pharmaceuticals (KDMP.OB) Initiates Development of Sublingual Anti-Cancer Drug, Gleevec(R)
1/12/2012 10:34:33 AM
More...
|
Kedem Pharmaceuticals (KDMP.OB) Completes North American Dosage Forms for X-Excite
1/6/2012 2:38:09 PM
More...
|
Kedem Pharmaceuticals (KDMP.OB) Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials
1/4/2012 11:13:11 AM
More...
|